Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
HES6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RALB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAGP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CASP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LETMD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORAI3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMS2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC71L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOMM34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLDC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC35F6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STEAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFITM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPYD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on